Shanta Dhar

Shanta Dhar is an Associate Professor in the Department of Biochemistry and Molecular Biology at the University of Miami, and serves as Assistant Director of Technology and Innovation at the Sylvester Comprehensive Cancer Center. She leads the NanoTherapeutics Research Laboratory, focusing on nanocarrier-mediated drug delivery for cancer, cardiovascular, and neurodegenerative diseases.

• Massachusetts Institute of Technology (2010)
• Johns Hopkins University (2007)
• Indian Institute of Science (2005)
• University of North Bengal (1998)

Her research integrates chemistry and biology to develop organelle-targeted nanoparticles, with applications in cancer immunotherapy, mitochondrial dysfunction treatment, and anti-viral nanotechnology. Recent work explores myeloid-derived suppressor cell modulation and spinal cord injury targeting.

Recent publications highlight interdisciplinary themes spanning photocatalytic materials, combination cancer therapies, and neuroinflammatory disease intervention. Key journals include ACS Nano, Langmuir, and Acta Biomaterialia.

Her lab develops mitochondria-targeted nanocarriers with chemistry-driven programs for pancreatic cancer, prostate cancer, and neurodegenerative disease therapies. The team conducts in vitro and pre-clinical testing of nanomedicine platforms for drug candidate discovery.